Close Menu

NEW YORK – Point-of-care test developer True Diagnostics said today that it has entered into a strategic alliance with Veravas to commercialize VeraTest Biotin, a portable test that rapidly screens patient samples to determine whether biotin levels are present that could throw off the accuracy of diagnostic tests.

VeraTest provides a 'yes' or 'no' answer to determine if biotin is above 15 ng/ml — levels that may impact patient test results, Carlsbad, California-based True Diagnostics said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.